These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 15919686)
1. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. Kollmannsberger C; Budach W; Stahl M; Schleucher N; Hehr T; Wilke H; Schleicher J; Vanhoefer U; Jehle EC; Oechsle K; Trarbach T; Boehlke I; Kanz L; Hartmann JT; Bokemeyer C Ann Oncol; 2005 Aug; 16(8):1326-33. PubMed ID: 15919686 [TBL] [Abstract][Full Text] [Related]
2. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. Oechsle K; Bokemeyer C; Hartmann JT; Budach W; Trarbach T; Stahl M; Boehlke I; Kollmannsberger C; J Cancer Res Clin Oncol; 2009 Feb; 135(2):163-72. PubMed ID: 18825411 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer. Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma. Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186 [TBL] [Abstract][Full Text] [Related]
5. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility. Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775 [TBL] [Abstract][Full Text] [Related]
7. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer. Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY Oncology; 2002; 63(3):239-47. PubMed ID: 12381903 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529 [TBL] [Abstract][Full Text] [Related]
9. The toxicity and outcomes of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected high-risk gastric cancer: results of a single institute. Yakir R; Luna K; Marc W; Tamar S; Avraham R; Ayala H Ann Acad Med Singap; 2008 Mar; 37(3):200-4. PubMed ID: 18392298 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer. Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277 [TBL] [Abstract][Full Text] [Related]
11. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer. Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
13. Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer. Welz S; Hehr T; Kollmannsberger C; Bokemeyer C; Belka C; Budach W Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1429-35. PubMed ID: 17692474 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262 [TBL] [Abstract][Full Text] [Related]
15. Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie. Lutz MP; Wilke H; Wagener DJ; Vanhoefer U; Jeziorski K; Hegewisch-Becker S; Balleisen L; Joossens E; Jansen RL; Debois M; Bethe U; Praet M; Wils J; Van Cutsem E; ; J Clin Oncol; 2007 Jun; 25(18):2580-5. PubMed ID: 17577037 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137 [TBL] [Abstract][Full Text] [Related]
18. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer. Wein A; Riedel C; Brückl W; Kastl S; Reingruber B; Hohenberger W; Hahn EG Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506 [TBL] [Abstract][Full Text] [Related]
19. Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. Pozzo C; Barone C; Szanto J; Padi E; Peschel C; Bükki J; Gorbunova V; Valvere V; Zaluski J; Biakhov M; Zuber E; Jacques C; Bugat R Ann Oncol; 2004 Dec; 15(12):1773-81. PubMed ID: 15550582 [TBL] [Abstract][Full Text] [Related]
20. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]